Chlorpromazine Tablets

Form: Oral Tablets

Strength: 10 mg, 25 mg, 50 mg, 100 mg, 200 mg

Reference Brands: Thorazine®(US); Largactil®(EU)

Category: Antipsychotropic Drugs

Chlorpromazine tablets are FDA-approved in the United States for the treatment of schizophrenia, bipolar disorder, severe behavioral issues, nausea, and intractable hiccups. In the European Union, they are available in select countries through national authorization procedures. Regulatory compliance requires GMP manufacturing, bioequivalence data, and robust safety documentation addressing sedation, extrapyramidal symptoms, and cardiovascular effects. U.S. submissions must align with FDA psychiatric drug labeling and pharmacovigilance standards. EU applications often require country-specific labeling and risk management plans. To explore dossier-ready Chlorpromazine tablets and alternative forms, visit Pharmatradz.com — your trusted B2B pharmaceutical sourcing platform.